Christopher Plant, PHD in Yorba Linda, CA - Medicare Clinical Psychologist Provider

Christopher Plant, PHD is a medicare enrolled "Psychologist" provider in Yorba Linda, California. He graduated from medical school in 2020 and has 4 years of diverse experience with area of expertise as Clinical Psychologist. He is a member of the group practice Chiron Psychological Inc and his current practice location is 18200 Yorba Linda Blvd Ste 106, Yorba Linda, California. You can reach out to his office (for appointments etc.) via phone at (714) 646-8034.

Christopher Plant is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538732524.

Contact Information

	Christopher Plant, PHD
	18200 Yorba Linda Blvd Ste 106, Yorba Linda, CA 92886-4006
	(714) 646-8034
	(714) 492-8264

Healthcare Provider's Profile

Full Name	Christopher Plant
Gender	Male
Speciality	Clinical Psychologist
Experience	4 Years
Location	18200 Yorba Linda Blvd Ste 106, Yorba Linda, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Christopher Plant graduated from medical school in 2020

NPI Data:

NPI Number: 1538732524
Provider Enumeration Date: 07/19/2021
Last Update Date: 09/15/2021

Medicare PECOS Information:

PECOS PAC ID: 8022412139
Enrollment ID: I20210811004450

Medical Identifiers

Medical identifiers for Christopher Plant such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538732524	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	(* (Not Available))	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Chiron Psychological Inc	9234496308	7

News Archive

New drug better than chemotherapy for skin cancer patients

A new drug, dabrafenib, shows improvements over chemotherapy for patients suffering from a form of advanced skin cancer, according to the results of a Phase III study ("BREAK-3" trial) published Online First in the Lancet.

Controversy surrounding McKinsey insurance survey continues

Though the consulting firm released its methodology, its findings continue to draw debate and criticism. Meanwhile, Avalere released a study of its own, which seems to contradict the McKinsey report.

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

While the benefits of androgen ablation therapy have been well documented in patients with locally advanced and metastatic prostate cancer, there is a paucity of evidence its role in patients with low-grade, low-stage disease.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Christopher Plant allows following entities to bill medicare on his behalf.

Entity Name	Chiron Psychological Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1467984377 PECOS PAC ID: 9234496308 Enrollment ID: O20171127003238

News Archive

New drug better than chemotherapy for skin cancer patients

Controversy surrounding McKinsey insurance survey continues

Though the consulting firm released its methodology, its findings continue to draw debate and criticism. Meanwhile, Avalere released a study of its own, which seems to contradict the McKinsey report.

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher Plant is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Christopher Plant, PHD 18200 Yorba Linda Blvd Ste 111, Yorba Linda, CA 92886-4043 Ph: (714) 646-8034	Christopher Plant, PHD 18200 Yorba Linda Blvd Ste 106, Yorba Linda, CA 92886-4006 Ph: (714) 646-8034

News Archive

New drug better than chemotherapy for skin cancer patients

Controversy surrounding McKinsey insurance survey continues

Though the consulting firm released its methodology, its findings continue to draw debate and criticism. Meanwhile, Avalere released a study of its own, which seems to contradict the McKinsey report.

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Psychologist in Yorba Linda, CA

Dr. Gregory Western, PSYD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18200 Yorba Linda Blvd, Suite #405, Yorba Linda, CA 92886 Phone: 714-420-7378
Dr. Sophia Anastasia Robinson, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 17451 Bastanchury Rd, Ste. 204-13, Yorba Linda, CA 92886 Phone: 714-779-2939
Dr. Brianna Bleeker, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16960 Bastanchury Rd Ste E, Yorba Linda, CA 92886 Phone: 714-455-9234
Dr. Kimberly Ann Miller, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 16960 Bastanchury Rd, Suite J, Yorba Linda, CA 92886 Phone: 714-623-0796
Dr. Susan Patricia Kaneshiro, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17451 Bastanchury Rd, Suite 204, Office 21, Yorba Linda, CA 92886 Phone: 714-404-7398 Fax: 888-958-5485
Debbie Kim, LEP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5275 Calle Sonora, Yorba Linda, CA 92887 Phone: 714-515-0044
Ashley Weintraub, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 18200 Yorba Linda Blvd Ste 106, Yorba Linda, CA 92886 Phone: 714-646-8034

Christopher Plant, PHD - Medicare Psychologist in Yorba Linda, CA

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

New drug better than chemotherapy for skin cancer patients

Controversy surrounding McKinsey insurance survey continues

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Medicare Reassignments

New drug better than chemotherapy for skin cancer patients

Controversy surrounding McKinsey insurance survey continues

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

New drug better than chemotherapy for skin cancer patients

Controversy surrounding McKinsey insurance survey continues

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Psychologist in Yorba Linda, CA